New York's Eyenovia Inc. added Kenneth Lee Jr., Charles Mather IV and Anthony Sun as independent members of its board of directors.

Lee and Sun will serve as chairman of the company's audit committee and compensation committee, respectively.

Lee is a general partner of a venture capital fund called Hatteras Venture Partners, while Mather is the managing director, co-head of equity capital markets at BTIG LLC. Sun held multiple posts at Aisling Capital Management LP, a private equity firm focused on life sciences.

Eyenovia develops therapies for eye diseases.